NCH2.DENCH2.DEXETRA
Loading
Year-over-year research & development expense growth
Latest
-35.25%
↓ 446% vs avg
Percentile
P13
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
10.18%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -35.25% |
| Q3 2025 | 39.00% |
| Q2 2025 | 25.00% |
| Q1 2025 | 14.29% |
| Q4 2024 | -35.78% |
| Q3 2024 | 3.81% |
| Q2 2024 | 14.13% |
| Q1 2024 | 70.37% |
| Q4 2023 | -19.40% |
| Q3 2023 | 31.37% |
| Q2 2023 | 15.91% |
| Q1 2023 | 37.50% |
| Q4 2022 | -39.62% |
| Q3 2022 | 35.90% |
| Q2 2022 | 15.83% |
| Q1 2022 | 0.00% |
| Q4 2021 | 0.00% |